Neratinib Maleate is used as an adjuvant therapy in people with early stage breast cancer in which HER2 is overexpressed, after the person receives treatment with trastuzumab. It is a tyrosine kinase inhibitor anticancer drug. Reference standards of Neratinib Maleate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Neratinib Maleate
Catalogue No.:PA 14 75000
CAS :
Molecular Formula : C34H33ClN6O7
Molecular Weight : 673.11
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....